Stay updated on SAF-189s in NSCLC: Phase I/II Clinical Trial
Sign up to get notified when there's something new on the SAF-189s in NSCLC: Phase I/II Clinical Trial page.

Latest updates to the SAF-189s in NSCLC: Phase I/II Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe record history adds a new revision entry (v3.6.5) and removes the previous revision (v3.6.4), reflecting an update to the study record.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedNew revision v3.6.4 has been added to the study record history, and the previous revision v3.6.3 has been removed from the history list. This updates the visible revision log to reflect the latest release and the removal of the earlier version.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry v3.6.3 is added to the study record history and v3.6.2 is removed, updating the revision timeline shown on the record.SummaryDifference0.1%

- Check60 days agoChange DetectedNew Revision: v3.6.2 appears in the study's version history, representing an updated release note for the record. The older Revision: v3.6.0 is removed from the current view, indicating the history has been updated to reflect the latest revision.SummaryDifference0.1%

- Check74 days agoChange DetectedExpanded sponsor identification to Fosunpharma (Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.). The study record's QC metadata shows a new version (Revision: v3.6.0), replacing the prior 'Verified' and 'Last known status was' entries from v3.5.5.SummaryDifference3%

- Check81 days agoChange DetectedThe record history now shows a new revision entry: Revision: v3.5.5, and the previous entry Revision: v3.5.4 has been removed. This indicates an updated release in the history log.SummaryDifference0.1%

Stay in the know with updates to SAF-189s in NSCLC: Phase I/II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAF-189s in NSCLC: Phase I/II Clinical Trial page.